Question 1

What is VERAXA Biotech AG?

Accepted Answer

VERAXA Biotech AG is a Entity.

Question 2

How often does VERAXA Biotech AG appear in global news?

Accepted Answer

Tracked across 9 news events drawn from 57 articles.

Question 3

When was VERAXA Biotech AG first tracked by Ergen?

Accepted Answer

First tracked on Jun 18, 2026.

Question 4

When was VERAXA Biotech AG last mentioned in news?

Accepted Answer

Last active on Jul 29, 2026.

Question 5

What is VERAXA Biotech AG's current news sentiment?

Accepted Answer

Aggregate sentiment score: 33 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is VERAXA Biotech AG in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 9 events.

Question 7

What is the most recent event involving VERAXA Biotech AG?

Accepted Answer

VERAXA BiTAC-ADC Platform Validated (Jun 18, 2026, 6 articles).

Question 8

Who is VERAXA Biotech AG most connected to?

Accepted Answer

Top relationships: Christoph Antz, Christoph Antz (ceo), Christoph Erkel.

Question 9

How did the "VERAXA BiTAC-ADC Platform Validated" event impact VERAXA Biotech AG?

Accepted Answer

VERAXA Biotech AG announced positive in vitro proof-of-concept data for its BiTAC-ADC technology platform, which could lead to more precise cancer therapies and enhance its market position. The company is seeking partnering opportunities based on this technology.

Question 10

How did the "VERAXA Biotech, ATUM Collaborate on BiTAC-TCE" event impact VERAXA Biotech AG?

Accepted Answer

VERAXA Biotech AG initiated cell line development for its lead BiTAC-TCE program with Atum, a crucial step towards clinical development and potential market entry for its cancer therapies.

Question 11

How did the "VERAXA Biotech pipeline update" event impact VERAXA Biotech AG?

Accepted Answer

VERAXA is the subject of the update, detailing its pipeline progress and strategic shift toward BiTAC platform, which is expected to drive future value.

Question 12

How did the "VERAXA Biotech partners with Ardigen" event impact VERAXA Biotech AG?

Accepted Answer

VERAXA is the primary beneficiary of the collaboration, gaining AI capabilities to enhance its BiTAC pipeline and potentially improve drug development success rates.

Question 13

How did the "VERAXA Biotech receives PEI scientific advice" event impact VERAXA Biotech AG?

Accepted Answer

VERAXA received supportive regulatory feedback for its lead BiTAC-TCE program, de-risking development and potentially enhancing its pipeline value.

Question 14

How did the "VERAXA Biotech appoints new CSO" event impact VERAXA Biotech AG?

Accepted Answer

VERAXA appointed a new CSO to lead its BiTAC platform development, indicating continuity in its strategic direction.

Question 15

How did the "VERAXA Biotech EGM approves resolutions" event impact VERAXA Biotech AG?

Accepted Answer

VERAXA is the company holding the EGM; the approved resolutions enhance its corporate flexibility for future growth.

Question 16

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.